Dataset from A Double-Blind, Randomized Study Comparing Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia

Key objectives of this clinical study are to: - Determine how well intramuscular (IM) olanzapine depot works compared to placebo - Evaluate the safety and tolerability of IM olanzapine depot compared to placebo - Evaluate different doses of IM olanzapine depot compared to placebo to identify the best dose(s).

本项临床研究的核心目标如下：
- 明确肌内注射（intramuscular, IM）奥氮平长效注射剂（olanzapine depot）与安慰剂的临床疗效差异；
- 评估肌内注射奥氮平长效注射剂相较于安慰剂的安全性与耐受性；
- 对比不同剂量的肌内注射奥氮平长效注射剂与安慰剂，以确定最优给药剂量。